Alpha 2.0
Login Register
» Articles » PMID: 32420691

Active Therapy with Passive Immunotherapy May Be Effective in the Fight Against COVID-19

Overview
Journal Clin Transl Sci
Specialties Biomedical Engineering
General Medicine
Date 2020 May 19
PMID 32420691
Citations 11
Authors
Christopher J Morabito
Bagirath Gangadharan
Affiliations
Soon will be listed here.
Citing Articles

AttABseq: an attention-based deep learning prediction method for antigen-antibody binding affinity changes based on protein sequences.

Jin R, Ye Q, Wang J, Cao Z, Jiang D, Wang T Brief Bioinform. 2024; 25(4).

PMID: 38960407 PMC: 11221889. DOI: 10.1093/bib/bbae304.

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature.

Delgado-Fernandez M, Garcia-Gemar G, Fuentes-Lopez A, Munoz-Perez M, Oyonarte-Gomez S, Ruiz-Garcia I Enferm Infecc Microbiol Clin (Engl Ed). 2022; 40(9):507-516.

PMID: 36336380 PMC: 9631336. DOI: 10.1016/j.eimce.2021.01.009.

COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?.

Rnjak D, Ravlic S, Sola A, Halassy B, Semnicki J, Superba M Transfus Clin Biol. 2021; 28(3):264-270.

PMID: 33901641 PMC: 8064810. DOI: 10.1016/j.tracli.2021.04.004.

Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Peng H, Rhind S, Beckett A JMIR Public Health Surveill. 2021; 7(4):e25500.

PMID: 33825689 PMC: 8245055. DOI: 10.2196/25500.

An overview of some potential immunotherapeutic options against COVID-19.

Bayat M, Asemani Y, Mohammadi M, Sanaei M, Namvarpour M, Eftekhari R Int Immunopharmacol. 2021; 95:107516.

PMID: 33765610 PMC: 7908848. DOI: 10.1016/j.intimp.2021.107516.

References
1.
Bloch E, Shoham S, Casadevall A, Sachais B, Shaz B, Winters J . Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020; 130(6):2757-2765. PMC: 7259988. DOI: 10.1172/JCI138745. View
2.
Lai S . Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis. 2005; 24(9):583-91. PMC: 7088345. DOI: 10.1007/s10096-005-0004-z. View
3.
Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H . Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019; 4(4). PMC: 6478436. DOI: 10.1172/jci.insight.123158. View
4.
Jaume M, Yip M, Cheung C, Leung H, Li P, Kien F . Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway. J Virol. 2011; 85(20):10582-97. PMC: 3187504. DOI: 10.1128/JVI.00671-11. View
5.
Duan K, Liu B, Li C, Zhang H, Yu T, Qu J . Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020; 117(17):9490-9496. PMC: 7196837. DOI: 10.1073/pnas.2004168117. View